Open the mobile version, with barcode scanning
Class III Terminated

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Why: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

Company
Gilead Sciences, Inc.
Foster City, CA, United States
Reported
Oct 15, 2014
Recall started
Sep 30, 2014
Ended
May 11, 2015
Where sold
Nationwide
Amount
10,317 bottles
Full product description
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
Lots / codes affected
TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.